ZEB2-AS1 has been found to be upregulated in urinary bladder cancer [155] and HCC [332], and to be partly responsible for the activation of ZEB2 during EMT induction by TGF-β1 in urinary bladder cancer cells [155]. The gene discussed is ZEB2; the disease is urinary bladder cancer.